Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Resource Use and Costs Associated to the Initial Phase of Treatment for Patients With Colorectal Cancer Receiving Post-Surgery Chemotherapy: A Cost Analysis From a Healthcare Perspective



Nejati M1 ; Razavi M2 ; Harirchi I1 ; Zanganeh M3 ; Salari G4 ; Tabatabaee SM3
Authors
Show Affiliations
Authors Affiliations
  1. 1. The Cancer Institute at Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. The Schneider Institutes for Health Policy at the Heller School of Brandeis University, Waltham, MA, United States
  3. 3. Deputy of Medical Affairs, Ministry of Health and Medical Education, Tehran, Iran
  4. 4. Iran Small Businesses and Industrial Parks Organization, Qazvin, Iran

Source: Iranian Journal of Public Health Published:2021

Abstract

Background: To estimate the resource use and costs associated to the initial phase of treatment for colorectal cancer in Iran. Methods: A retrospective study was conducted using routinely collected data within Electronic Health Records System (SEPAS), a national database representing public hospitals in Iran between March 20, 2016 and March 19, 2017. Primary end points included healthcare resource use, direct medical and non-medical costs of care in the 12-month study period. Results: The study population included 657 patients with colorectal cancer who underwent surgery and the fol-low-up chemotherapy. We estimated a total direct cost of $21,407 per patient. The results indicated that direct medical costs were primarily driven by inpatient hospital care, followed by surgery, chemotherapy, and diagnostic services. Conclusion: The initial 12-month of treatment for colorectal cancer, including surgery and the follow-up chem-otherapy, is resource intensive. The total direct costs associated to the disease are remarkable, with Inpatient hospital services being the main contributor followed by surgery and chemotherapy. © 2021 Nejati et al.
Other Related Docs
10. Circular Rnas (Circrnas) in Cancer Proliferation: Molecular Interactions and Possible Therapeutic Targets, Non-coding RNA Transcripts In Cancer Therapy: Pre-clinical And Clinical Implications (2023)
11. Nanoparticulate Systems for Dental Drug Delivery, Nanoengineered Biomaterials for Advanced Drug Delivery (2020)
22. Economic Burden of Gynecological Cancers in Iran, Value in Health Regional Issues (2022)
24. The Role of Cxc Chemokines and Receptors in Breast Cancer, Clinical and Experimental Medicine (2025)